Genomic characterization and molecular predictive biomarkers for chemotherapy in a real-world population with metastatic triple-negative breast cancer

被引：0
|
作者：
Olsson, Erik
Lindman, Henrik
Digkas, Evangelos
Thurfjell, Viktoria
Ali, Haidar Mir
Kruger, Ute
Wennstig, Anna-Karin
Sundqvist, Marie
Valachis, Antonis
机构：
来源：
CANCER RESEARCH | 2024年 / 84卷 / 09期
关键词：
D O I：
10.1158/1538-7445.SABCS23-PO4-15-05
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
PO4-15-05
引用
收藏
页数：3
相关论文
共 50 条
  • [41] Treatment of Metastatic Triple-Negative Breast Cancer
    Glendenning, Jennifer
    Irshad, Sheeba
    Tutt, Andrew
    CURRENT BREAST CANCER REPORTS, 2012, 4 (01) : 10 - 21
  • [42] Treatment of Metastatic Triple-Negative Breast Cancer
    Jennifer Glendenning
    Sheeba Irshad
    Andrew Tutt
    Current Breast Cancer Reports, 2012, 4 (1) : 10 - 21
  • [43] RNA molecular signatures as predictive biomarkers of response to monotherapy pembrolizumab in patients with metastatic triple-negative breast cancer: KEYNOTE-086
    Loi, Sherene
    Schmid, Peter
    Cortes, Javier
    Cescon, David W.
    Winer, Eric P.
    Toppmeyer, Deborah
    Rugo, Hope S.
    De Laurentiis, Michelino
    Nanda, Rita
    Iwata, Hiroji
    Awada, Ahmad
    Tan, Antoinette
    Zhang, Chunsheng
    Loboda, Andrey
    Albright, Andrew
    Cristescu, Razvan
    Lane, Maureen
    Wang, Anran
    Lunceford, Jared
    Aktan, Gursel
    Karantza, Vassiliki
    Adams, Sylvia
    CANCER RESEARCH, 2019, 79 (13)
  • [44] Triple-negative breast cancer: molecular characterization and targeted therapies
    Nicholson, Allen
    Bishop, Jennifer
    Lannin, Donald
    Killelea, Brigid
    Guo, Xiaojia
    Cha, Charles
    Dixon, J. Michael
    BREAST CANCER MANAGEMENT, 2013, 2 (05) : 417 - 430
  • [45] Characterization of an Immunogenic Mutation in a Patient with Metastatic Triple-Negative Breast Cancer
    Assadipour, Yasmine
    Zacharakis, Nikolaos
    Crystal, Jessica S.
    Prickett, Todd D.
    Gartner, Jared J.
    Somerville, Robert P. T.
    Xu, Hui
    Black, Mary A.
    Jia, Li
    Chinnasamy, Harshini
    Kriley, Isaac
    Lu, Lily
    Wunderlich, John R.
    Zheng, Zhili
    Lu, Yong-Chen
    Robbins, Paul F.
    Rosenberg, Steven A.
    Goff, Stephanie L.
    Feldman, Steven A.
    CLINICAL CANCER RESEARCH, 2017, 23 (15) : 4347 - 4353
  • [46] Spatial characterization of the tumor microenvironment of metastatic triple-negative breast cancer
    Bhargava, Mahak
    Kaur, Jaspreet
    Saini, Geetanjali
    Zheng, Junjun
    Xu, Yitian
    Chen, Shu-Hsia
    Pan, Ping-Ying
    Rewcastle, Emma
    Kiraz, Umay
    Janssen, Emiel Adrianus
    Aneja, Ritu
    CANCER RESEARCH, 2024, 84 (06)
  • [47] Identification of predictive markers for clinical efficacy of triple-negative breast cancer chemotherapy
    Yun, Jihui
    Hur, Saem
    Kang, Wonyoung
    Na, Deukchae
    Chae, Jeesoo
    Kang, Jinjoo
    Kim, Ju-Hee
    Lee, Jiwoo
    Heo, Woohang
    Han, Wonshik
    Lee, Charles
    Noh, Dong-Young
    Moon, Hyeong-Gon
    Kim, Jong-Il
    CANCER RESEARCH, 2018, 78 (13)
  • [48] Real-world treatment and survival outcomes in previously untreated patients with metastatic triple-negative breast cancer (mTNBC) in the United States (US)
    Punie, K.
    Kurian, A.
    Ntalla, I.
    Huynh, D. H.
    Sadetsky, N.
    Estrin, A.
    Dabrowski, E.
    Sjekloca, N.
    Lai, C.
    Hurvitz, S. A.
    ANNALS OF ONCOLOGY, 2023, 34 : S347 - S348
  • [49] Real-world data comparing third and subsequent line regimens for treatment of metastatic triple-negative breast cancer in the United States.
    Aran, Dvir
    Klein-Brill, Avital
    Fisch, Michael Jordan
    Amar-Farkash, Shlomit
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16) : E18765 - E18765
  • [50] Real-world outcomes of systemic therapy for advanced triple-negative breast cancer: a tertiary centre experience
    Zhang, Shuai
    Coriano, Matilde
    Mac Eochagain, Colm
    Yang, Dorothy
    Yiu, Daniel
    Ring, Alistair
    Battisti, Nicolo M. L.
    CANCER RESEARCH, 2024, 84 (09)
12345